Get research updatesBipolarity involves episodes of depression and periods of elevated or irritable mood, with unusually high energy and activity.
A Double-Blind Study Examining the Efficacy of the Protein Kinase C Inhibitor Tamoxifen in the Treatment of Acute Mania
This study has finished and is no longer accepting participants.
In Washington D.C.Olanzapine Versus Placebo in the Treatment of Mania in Adolescents With Bipolar I Disorder
This study has finished and is no longer accepting participants.
In IndianapolisOlanzapine Versus Divalproex and Placebo in the Treatment of Mild to Moderate Mania Associated With Bipolar I Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including ScottsdaleResearchers are studying Olanzapine to find out how it affects manic symptoms in people with bipolarity during a manic episode.
This study ended early.
In ClevelandA Double-Blind, Placebo-Controlled Trial of Seroquel for the Treatment of Dysphoric Hypomania in Bipolar II Patients
This study has finished and is no longer accepting participants.
In StanfordResearchers compared Cariprazine (RGH-188) and placebo to find out how the approaches affected manic symptoms in people with bipolarity type I during a manic episode.
This study has finished and is no longer accepting participants.
In St LouisThis study evaluated the effectiveness of aripiprazole for people with bipolarity.
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockStudy of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including La Palma
The Role of Molecules in Blood Cells for Diagnosing Bipolar Disorders
This study ended early.
In ClevelandA Twelve-Week, Open, Randomized Trial Comparing Valproate to Lithium in Bipolar I Patients Suffering From a Manic Episode
This study has finished and is no longer accepting participants.
Location not clearly listed
This study isn't currently recruiting.
In GermanyThe Efficacy And Safety Of Flexible Dosage Ranges Of Risperidone Versus Placebo In The Treatment Of Manic Or Mixed Episodes Associated With Bipolar I Disorder
This study has finished and is no longer accepting participants.
Location not clearly listedWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.